TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | -59.29%506M | 537.76%2.27B | 193.95%1.24B | -117.20%-519M | -188.14%-1.32B | -5.06%3.02B | 61.05%1.5B | 39.00%3.18B | -35.46%932M | -35.70%2.29B |
Profit adjustment | ||||||||||
Investment loss (gain) | ---- | -164.00%-14.52B | ---- | 290.69%22.68B | ---- | 57.76%-11.9B | 74.06%-2.96B | 55.51%-28.16B | 72.43%-11.4B | -26,474.58%-63.3B |
Special items | 653.14%1.32B | 133.78%8.45B | -107.86%-239M | -565.61%-25.02B | 13.18%3.04B | -78.42%5.37B | -77.79%2.69B | -55.83%24.89B | -68.91%12.09B | 1,243.46%56.36B |
Operating profit before the change of operating capital | 82.07%1.83B | -32.90%-3.79B | -41.49%1B | 18.55%-2.85B | 39.74%1.72B | -3,793.33%-3.5B | -24.06%1.23B | 98.06%-90M | 255.78%1.62B | -310.87%-4.65B |
Change of operating capital | ||||||||||
Cash from business operations | 82.07%1.83B | -32.90%-3.79B | -41.49%1B | 18.55%-2.85B | 39.74%1.72B | -3,793.33%-3.5B | -24.06%1.23B | 98.06%-90M | 255.78%1.62B | -310.87%-4.65B |
Other taxs | ---- | 9.58%-406M | ---- | 0.88%-449M | ---- | 17.79%-453M | ---- | 23.15%-551M | ---- | -50.31%-717M |
Dividend received - operating | ---- | 8.34%1.65B | ---- | 2.91%1.52B | ---- | 13.41%1.48B | ---- | 33.44%1.31B | ---- | 31.45%978M |
Interest received - operating | ---- | 10.93%2.87B | ---- | 11.21%2.59B | ---- | 27.00%2.33B | ---- | -57.14%1.83B | ---- | 9.33%4.28B |
Interest paid - operating | ---- | -368.75%-75M | ---- | -45.45%-16M | ---- | 56.00%-11M | ---- | ---25M | ---- | ---- |
Special items of business | 31.18%345M | 104.91%584M | --263M | -34.93%285M | ---- | 45.51%438M | ---- | 413.54%301M | ---- | -131.17%-96M |
Net cash from operations | 71.51%2.17B | -22.82%832M | -26.17%1.27B | 287.77%1.08B | 39.74%1.72B | -89.97%278M | -24.06%1.23B | 1,426.79%2.77B | 255.78%1.62B | -106.23%-209M |
Cash flow from investment activities | ||||||||||
Sale of fixed assets | ---- | --2M | ---- | ---- | ---- | ---- | ---- | --6M | ---- | ---- |
Purchase of fixed assets | -50.00%-27M | -29.41%-44M | -28.57%-18M | 5.56%-34M | 26.32%-14M | 36.84%-36M | 54.76%-19M | 10.94%-57M | -100.00%-42M | 52.24%-64M |
Purchase of intangible assets | -23.35%-243M | -39.26%-415M | 10.86%-197M | 61.45%-298M | ---221M | 32.31%-773M | ---- | -79.84%-1.14B | ---- | -43.67%-635M |
Recovery of cash from investments | ---- | -6.83%273M | 59.65%273M | 253.01%293M | --171M | --83M | ---- | ---- | ---- | ---- |
Other items in the investment business | ---- | ---176M | ---- | ---- | ---- | ---- | -5.46%-773M | ---- | -618.63%-733M | --375M |
Net cash from investment operations | -565.52%-270M | -823.08%-360M | 190.63%58M | 94.63%-39M | 91.92%-64M | 39.15%-726M | -2.19%-792M | -268.21%-1.19B | -530.08%-775M | 43.75%-324M |
Net cash before financing | 43.62%1.9B | -54.57%472M | -19.79%1.33B | 331.92%1.04B | 278.90%1.65B | -128.35%-448M | -48.22%436M | 396.44%1.58B | 172.52%842M | -119.18%-533M |
Cash flow from financing activities | ||||||||||
Issuing shares | ---- | 200.00%4M | --4M | -100.17%-4M | ---- | 18,223.08%2.38B | -20.00%8M | -40.91%13M | -23.08%10M | -4.35%22M |
Interest paid - financing | 24.49%-74M | 7.84%-188M | 16.24%-98M | 35.03%-204M | 28.22%-117M | -6.80%-314M | -10.88%-163M | 44.11%-294M | 49.13%-147M | -4.78%-526M |
Dividends paid - financing | -7.95%-394M | -12.03%-540M | -12.31%-365M | -12.09%-482M | -13.64%-325M | 48.32%-430M | 58.55%-286M | 49.08%-832M | 37.73%-690M | 1.68%-1.63B |
Issuance expenses and redemption of securities expenses | ---60M | 81.06%-393M | ---- | ---2.08B | ---2.08B | ---- | ---- | ---- | ---- | -14.91%-686M |
Other items of the financing business | ---- | ---- | -207.23%-371M | 235.69%346M | --346M | -125.94%-255M | ---- | 167.85%983M | 640.11%983M | -82.35%367M |
Net cash from financing operations | 35.04%-571M | 51.98%-1.21B | 60.53%-879M | -299.21%-2.52B | -349.90%-2.23B | 590.31%1.27B | -580.58%-495M | 89.50%-258M | 104.98%103M | -272.84%-2.46B |
Effect of rate | -162.50%-105M | 85.71%-25M | 77.78%-40M | -297.73%-175M | -318.60%-180M | -162.86%-44M | 27.12%-43M | -65.52%70M | -690.00%-59M | 138.37%203M |
Other items affecting net cash | ---- | ---- | ---- | ---- | ---- | -378.17%-1.62B | -186.30%-460M | 94.04%-339M | 82.53%533M | -832.79%-5.69B |
Net Cash | 198.65%1.33B | 50.17%-738M | 177.57%446M | -84.20%-1.48B | -10.79%-575M | -181.79%-804M | -135.12%-519M | 111.32%983M | 150.29%1.48B | -674.83%-8.68B |
Begining period cash | -13.84%4.75B | -23.10%5.51B | -23.10%5.51B | -10.58%7.17B | -10.58%7.17B | 15.12%8.02B | 15.12%8.02B | -54.90%6.97B | -54.90%6.97B | 6.78%15.44B |
Cash at the end | 0.98%5.98B | -13.84%4.75B | -7.72%5.92B | -23.10%5.51B | -13.96%6.42B | -10.58%7.17B | -11.07%7.46B | 15.12%8.02B | -33.00%8.38B | -54.90%6.97B |
Cash balance analysis | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Ernst & Young LLP | -- | KPMG Audit Plc | -- | KPMG Audit Plc | -- | KPMG Audit Plc | -- | KPMG Audit Plc |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.